+31.5%
CVS vs SBAC
-43.9%
+75.5%
-56.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | SBAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.7% | -0.4% | -0.3% | -0.6% |
| 7D | -1.6% | -0.1% | -1.5% | -1.6% |
| 30D | +0.4% | +3.2% | -2.9% | -0.1% |
| 3M | -0.4% | -5.1% | +4.6% | +0.2% |
| 6M | +25.1% | -2.1% | +27.3% | +25.0% |
| YTD | +23.9% | -0.5% | +24.4% | +23.2% |
| 1Y | +41.1% | +1.1% | +39.9% | +39.9% |
| 3Y | +63.6% | -7.4% | +71.1% | +62.5% |
| 5Y | +31.5% | -44.3% | +75.9% | +40.0% |
| All | +31.5% | -43.9% | +75.5% | +40.0% |
Cumulative growth
Daily Returns
Daily percentage return beside SBAC.
Daily Out/Under-Performance
Portfolio return minus SBAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling